Basic Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 28, 2022; 28(32): 4620-4634
Published online Aug 28, 2022. doi: 10.3748/wjg.v28.i32.4620
Table 5 Blood biochemical parameters and electrolyte profiles in different treatment groups
No.
Group
Creatinine, mmol/L
Urea,mmol/L
Uric acid, mmol/L
AKT, U/L
AST, U/L
ALT, U/L
GGT, U/L
Total protein, g/L
Albumin, g/L
Globulin, g/L
Albumin/ Globulin ratio
Total Bilirubin, µmol/L
Na
K
CL
1Untreated28.1 ± 1.58.80 ± 0.90.20 ± 0.096.0 ± 0.5195 ± 0.773.0 ± 0.7< 3.0 ± 0.050.0 ± 0.530.0 ± 1.123.0 ± 0.51.40 ± 0.3< 2.0 ± 0.0178 ± 0.38.00 ± 0.7124 ± 1.1
2Gemcitabine (10 mg/kg per 3 d)28.0 ± 1.99.00 ± 1.10.16 ± 0.193.0 ± 1.1190 ± 0.972.0 ± 0.9< 3.0 ± 0.052.0 ± 1.232.0 ± 0.724.0 ± 0.71.40 ± 0.2< 2.0 ± 0.0173 ± 0.59.30 ± 0.4123 ± 0.2
3O.s (200 mg/kg per day)29.0 ± 1.59.20 ± 1.30.19 ± 0.098.0 ± 1.2201 ± 1.180.0 ± 1.1< 3.0 ± 0.050.5 ± 0.733.0 ± 0.323.0 ± 0.71.30 ± 0.3< 2.0 ± 0.0174 ± 0.89.00 ± 0.8128 ± 0.9
4O.s (200 mg/kg per day) and gemcitabine (10 mg/kg per 3 d) combination27.5 ± 1.19.50 ± 0.90.21 ± 0.1101 ± 0.9210 ± 0.777.0 ± 0.7< 3.0 ± 0.051.3 ± 1.129.9 ± 0.922.5 ± 0.91.30 ± 0.2< 2.0 ± 0.0186 ± 0.98.60 ± 0.6130 ± 1.1
5O.s (400 mg/kg per day)28.5 ± 0.98.80 ± 0.70.22 ± 0.1101 ± 0.7199 ± 0.966.0 ± 0.5< 3.0 ± 0.051.9 ± 0.532.4 ± 0.825.0 ± 0.91.40 ± 0.2< 2.0 ± 0.0190 ± 0.410.0 ± 0.5133 ± 0.9
6O.s (400 mg/kg per day) and gemcitabine (10 mg/kg per 3 d) combination27.0 ± 0.88.50 ± 1.30.21 ± 0.0103 ± 0.8190 ± 0.770.0 ± 0.9< 3.0 ± 0.052.0 ± 0.730.5 ± 0.624.0 ± 0.71.40 ± 0.1< 2.0 ± 0.0185 ± 0.69.80 ± 0.9123 ± 0.5